InvestorsHub Logo
Post# of 253228
Next 10
Followers 260
Posts 18201
Boards Moderated 0
Alias Born 01/19/2006

Re: maverick_1 post# 195633

Monday, 10/05/2015 8:25:23 AM

Monday, October 05, 2015 8:25:23 AM

Post# of 253228
How would you compare that gene therapy vis a vis the cell therapy of OCAT for, so far, other eye conditions that also lead to blindness, like dryAMD and Stargardt's macular degeneration[dystrophy]?
Join InvestorsHub

Join the InvestorsHub Community

Register for free to join our community of investors and share your ideas. You will also get access to streaming quotes, interactive charts, trades, portfolio, live options flow and more tools.